Tag: drugdevelopment

Expanded antibody portfolio enhances detection of biologics and therapeutics for bioanalytical applications

AstraZeneca to seek accelerated approval of Ultomirisin in immunoglobulin A nephropathy on phase 3 data

Tenvie doses first subject in phase 1 TNV108 trial for peripheral neuropathies

IRBM reports progress in drug discovery for Zika virus

Sofetabart mipitecan receives ‘Breakthrough Therapy’ designation for the treatment of certain patients with platinum-resistant ovarian cancer

Positive phase 3 topline results for oral infigratinib

FDA removes barriers to cell, gene therapy development

IRBM reports progress in drug discovery for Zika virus

Takeda presents new data shows mezagitamab’s (TAK-079) sustained effect on kidney function 18 months after treatment in primary IgA nephropathy

Amgen advances toward lupus redemption while gastric cancer candidate struggles